| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 2 | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 2.70 |
—
—
—
|
| 2025 | 2.68 |
—
—
—
—
|
| 2024 | 2.68 |
—
—
—
—
|
| 2023 | 2.68 |
—
—
—
—
|
| 2022 | 2.68 |
—
—
—
—
|
| 2021 | 2.68 |
—
—
—
—
|
| 2020 | 2.68 |
—
—
—
—
|
| 2019 | 2.65 |
—
—
—
—
|
| 2018 | 2.64 |
—
—
—
—
|
| 2017 | 2.54 |
—
—
—
—
|
| 2016 | 2.36 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 444.73 | 548.74 | 54.56 | 184.21 |
| Receivables | 287.50 | 344.89 | 340.05 | 546.26 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 1,944.40 | 2,321.92 | 1,775.56 | 2,097.21 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | — | — | — | — |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 287.80 | 328.19 | 352.55 | 347.86 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 322.96 | 328.25 | — | — |
—
|
| ’25 | 276.79 | 282.51 | 311.59 | 319.22 |
1,190.10
|
| ’24 | 243.30 | 252.75 | 276.03 | 279.32 |
1,051.39
|
| ’23 | 218.20 | 250.19 | 242.03 | 239.32 |
949.74
|
| ’22 | 249.32 | 244.65 | 239.43 | 144.85 |
878.24
|
| ’21 | 273.77 | 257.42 | 281.67 | 249.95 |
1,062.81
|
| ’20 | 253.02 | 256.40 | 119.18 | 263.79 |
892.38
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 215.50 | 217.72 | — | — |
—
|
| ’25 | 181.95 | 239.27 | 226.71 | 230.62 |
878.55
|
| ’24 | 151.47 | 184.10 | 184.89 | 228.97 |
749.43
|
| ’23 | 111.36 | 170.38 | 171.02 | 164.98 |
617.74
|
| ’22 | 132.20 | 172.99 | 166.85 | 153.68 |
625.73
|
| ’21 | 175.98 | 202.35 | 187.28 | 156.53 |
722.14
|
| ’20 | 139.07 | 190.38 | 181.45 | 197.36 |
708.26
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 77.69 | 654.61 | — | — |
—
|
| ’25 | 88.33 | (107.21) | 217.38 | (117.43) |
81.06
|
| ’24 | 116.77 | 79.57 | 81.51 | (43.78) |
234.07
|
| ’23 | 92.42 | 6.52 | 90.23 | 83.61 |
272.78
|
| ’22 | 333.38 | 211.27 | (264.44) | 51.18 |
331.39
|
| ’21 | (432.35) | 173.13 | 88.04 | 137.43 |
(33.75)
|
| ’20 | 97.58 | 134.80 | 162.27 | 101.75 |
496.41
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.47 | 1.19 | — | — |
—
|
| ’25 | 0.33 | 0.46 | 0.59 | 0.55 |
1.94
|
| ’24 | 0.27 | 0.45 | 0.42 | 0.41 |
1.55
|
| ’23 | 0.15 | 0.25 | 0.37 | 0.22 |
1.00
|
| ’22 | 0.79 | 0.38 | 0.43 | 0.19 |
1.80
|
| ’21 | 0.69 | 0.36 | 0.58 | 0.14 |
1.75
|
| ’20 | 0.39 | 0.43 | (0.40) | 0.27 |
0.70
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.81 | 25.61 | 27.53 | 35.04 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.71 | 34.77 | 44.42 | 46.36 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 52 | 57 | 60 | 69 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.89 | 16.66 | 17.52 | 17.25 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 878.24 | 949.74 | 1,051.39 | 1,190.10 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 100.00% | 100.00% | 100.00% | 100.00% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 436.14 | 255.63 | 420.75 | 624.43 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 49.66% | 26.92% | 40.02% | 52.47% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 438.84 | 248.80 | 417.80 | 609.47 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 340.08 | 333.87 | 316.79 | 326.22 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.72 | 3.95 | 4.07 | 4.08 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡ | 1.81 | 1.01 | 1.57 | 1.96 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.65 | 2.57 | 2.90 | 3.01 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.25) | (1.43) | (2.00) | (2.73) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.40 | 1.13 | 0.91 | 0.28 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.10 | 15.64 | 18.33 | 18.65 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 236.26 | 240.49 | 258.12 | 291.65 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.53 | 31.16 | 24.11 | 22.74 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.52 | 7.81 | 9.29 | 10.87 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.74 | 1.97 | 2.07 | 2.38 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.61 | 13.05 | 13.71 | 11.32 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.07 | 45.43 | 61.56 | 166.15 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 625.73 | 617.74 | 749.43 | 878.55 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (294.34) | (344.96) | (515.36) | (797.49) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 331.39 | 272.78 | 234.07 | 81.06 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,261.84 | 1,656.60 | 1,993.73 | 1,423.01 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,646.83 | 5,067.32 | 4,838.86 | 4,256.01 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,346.19 | 4,622.59 | 4,290.12 | 4,201.45 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,803.28 | 3,762.29 | 4,730.84 | 5,440.50 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.61% | 2.69% | 4.40% | 5.93% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.13% | 2.92% | 4.32% | 4.65% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.09% | 6.59% | 9.85% | 11.63% | ‡‡‡‡ | — | — |
ROE
|
Omega Healthcare Investors (OHI), a leading healthcare REIT focused on skilled nursing and assisted living facilities, has shown resilience amid COVID disruptions, inflation, and rate hikes, with revenue growing at a 3.2% CAGR from $901 million in 2016 to a projected $1.19 billion in 2025. Despite share dilution and pandemic dips, operational efficiency shines through 100% gross margins, ROE stabilizing at 12%, and deleveraging that slashed debt 25% to $4.26 billion by 2025, bolstering liquidity and dividend coverage at 1.5-2x via AFFO.
Trading near analyst consensus with flat near-term returns but 25% upside potential to highs and only 9% downside risk, OHI benefits from insider buys (CEO/CIO scooping up 31,500 shares) and demographic tailwinds. However, volatile FCF, capex drag, tenant concentration (>20% from top operators), and lingering debt at 78% of equity pose risks amid rate persistence and operator cyclicality—making it a cautious hold for income seekers, with full details revealing the quantitative edge.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.